© BrainNet Europe II
BrainNet Europe is a "Network of Excellence" funded by the European Commission in the 6th Framework Program "Life Science" (LSHM-CT-2004-503039). It consists of 19 established brain banks across Europe and is coordinated by the Centre for Neuropathology and Prion Research Ludwig-Maximilians-University Munich, Germany.
|WP15 - Standardisation of Neuropathological Criteria and Diagnostics|
The ultimate goal is to facilitate the use of human brain tissue in research and to supply the researchers in various fields of neuroscience with brain tissue of optimal quality (see also WP01, WP03). This requires both clinical and neuropathological diagnostic security. One requirement is that both the clinical and especially the neuropathological diagnostic criteria used within the consortium are harmonised. A disease (e.g. Alzheimer's Disease) is defined as a clinical condition whereas tissue specific lesions with specific distribution are to be found. Additional to this for the diagnosis of AD, specific clinical symptoms with special progression are required. Based on the above diagnostic consensus criteria have been produced and published previously fore a selection of neurological diseases.
The objectives of this work package are:
It should be emphasised that the BrainNet Europe consortium is dealing with neuropathological entities and if and when needed clinicians (neurologists, psychiatrists, gerontologists) are to be consulted in order to facilitate the production of clinico-pathological consensus criteria.
previous / next